These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17337596)

  • 1. The protein kinase C pathway mediates cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2.
    House SL; Melhorn SJ; Newman G; Doetschman T; Schultz Jel J
    Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H354-65. PubMed ID: 17337596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2 is mediated by the MAPK cascade.
    House SL; Branch K; Newman G; Doetschman T; Schultz Jel J
    Am J Physiol Heart Circ Physiol; 2005 Nov; 289(5):H2167-75. PubMed ID: 16040717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: the role of JNK signaling.
    Liao S; Porter D; Scott A; Newman G; Doetschman T; Schultz Jel J
    J Mol Cell Cardiol; 2007 Jan; 42(1):106-20. PubMed ID: 17150229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia.
    House SL; Bolte C; Zhou M; Doetschman T; Klevitsky R; Newman G; Schultz Jel J
    Circulation; 2003 Dec; 108(25):3140-8. PubMed ID: 14656920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low molecular weight fibroblast growth factor-2 signals via protein kinase C and myofibrillar proteins to protect against postischemic cardiac dysfunction.
    Manning JR; Perkins SO; Sinclair EA; Gao X; Zhang Y; Newman G; Pyle WG; Schultz Jel J
    Am J Physiol Heart Circ Physiol; 2013 May; 304(10):H1382-96. PubMed ID: 23479264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of FGF2 high molecular weight (HMW) isoforms in the development of cardiac ischemia-reperfusion injury.
    Liao S; Bodmer JR; Azhar M; Newman G; Coffin JD; Doetschman T; Schultz Jel J
    J Mol Cell Cardiol; 2010 Jun; 48(6):1245-54. PubMed ID: 20116383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoproteomic analysis identifies phospho-Threonine-17 site of phospholamban important in low molecular weight isoform of fibroblast growth factor 2-induced protection against post-ischemic cardiac dysfunction.
    Manning JR; Wijeratne AB; Oloizia BB; Zhang Y; Greis KD; Schultz JEJ
    J Mol Cell Cardiol; 2020 Nov; 148():1-14. PubMed ID: 32853649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits.
    Ping P; Zhang J; Cao X; Li RC; Kong D; Tang XL; Qiu Y; Manchikalapudi S; Auchampach JA; Black RG; Bolli R
    Am J Physiol; 1999 May; 276(5):H1468-81. PubMed ID: 10330229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways.
    Hu Y; Chen X; Pan TT; Neo KL; Lee SW; Khin ES; Moore PK; Bian JS
    Pflugers Arch; 2008 Jan; 455(4):607-16. PubMed ID: 17674030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor-2-induced cardioprotection against myocardial infarction occurs via the interplay between nitric oxide, protein kinase signaling, and ATP-sensitive potassium channels.
    Manning JR; Carpenter G; Porter DR; House SL; Pietras DA; Doetschman T; Schultz Jel J
    Growth Factors; 2012 Apr; 30(2):124-39. PubMed ID: 22304432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of erythropoietin-mediated cardioprotection during ischemia-reperfusion injury: role of protein kinase C and phosphatidylinositol 3-kinase signaling.
    Hanlon PR; Fu P; Wright GL; Steenbergen C; Arcasoy MO; Murphy E
    FASEB J; 2005 Aug; 19(10):1323-5. PubMed ID: 15946993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive protection of the ischemic heart ex vivo by combined treatment with delta-protein kinase C inhibitor and epsilon-protein kinase C activator.
    Inagaki K; Hahn HS; Dorn GW; Mochly-Rosen D
    Circulation; 2003 Aug; 108(7):869-75. PubMed ID: 12860903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-activating factor induces cardioprotection in isolated rat heart akin to ischemic preconditioning: role of phosphoinositide 3-kinase and protein kinase C activation.
    Penna C; Alloatti G; Cappello S; Gattullo D; Berta G; Mognetti B; Losano G; Pagliaro P
    Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2512-20. PubMed ID: 15637120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced cardiac CapZ protein protects hearts against acute ischemia-reperfusion injury and enhances preconditioning.
    Yang FH; Pyle WG
    J Mol Cell Cardiol; 2012 Mar; 52(3):761-72. PubMed ID: 22155006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways.
    Chen Y; Ba L; Huang W; Liu Y; Pan H; Mingyao E; Shi P; Wang Y; Li S; Qi H; Sun H; Cao Y
    Eur J Pharmacol; 2017 Feb; 796():90-100. PubMed ID: 27916558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF-2-induced negative inotropism and cardioprotection are inhibited by chelerythrine: involvement of sarcolemmal calcium-independent protein kinase C.
    Padua RR; Merle PL; Doble BW; Yu CH; Zahradka P; Pierce GN; Panagia V; Kardami E
    J Mol Cell Cardiol; 1998 Dec; 30(12):2695-709. PubMed ID: 9990540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G Protein-Coupled Estrogen Receptor 1 Mediates Acute Estrogen-Induced Cardioprotection via MEK/ERK/GSK-3β Pathway after Ischemia/Reperfusion.
    Kabir ME; Singh H; Lu R; Olde B; Leeb-Lundberg LM; Bopassa JC
    PLoS One; 2015; 10(9):e0135988. PubMed ID: 26356837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of FGF-2 increases cardiac myocyte viability after injury in isolated mouse hearts.
    Sheikh F; Sontag DP; Fandrich RR; Kardami E; Cattini PA
    Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1039-50. PubMed ID: 11179045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotection via activation of protein kinase C-delta depends on modulation of the reverse mode of the Na+/Ca2+ exchanger.
    Bouwman RA; Salic K; Padding FG; Eringa EC; van Beek-Harmsen BJ; Matsuda T; Baba A; Musters RJ; Paulus WJ; de Lange JJ; Boer C
    Circulation; 2006 Jul; 114(1 Suppl):I226-32. PubMed ID: 16820577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obestatin affords cardioprotection to the ischemic-reperfused isolated rat heart and inhibits apoptosis in cultures of similarly stressed cardiomyocytes.
    Alloatti G; Arnoletti E; Bassino E; Penna C; Perrelli MG; Ghé C; Muccioli G
    Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H470-81. PubMed ID: 20525876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.